Description
IGF::OT::IGF DIALYSIS SYSTEM LEASES
First action · last action
2014-10-01 · 2014-10-01
Transactions
1
First transaction's obligation
$2,640
Base + all options value (sum of deltas)
$2,640
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
334510 · ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$2,640= $2,640
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$2,640 | $2,640 | IGF::OT::IGF DIALYSIS SYSTEM LEASES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RSKLEFCZ6127)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0776 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $22,990 | FY2026 |
| 36C26226N0708 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $387,926 | FY2026 |
| 36C26226D0102 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026P0469 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $114,588 | FY2026 |
| 36C24826N0573 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $30,000 | FY2026 |
| 36C24826A0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q999 from 596-LEXINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24916P0697 | COVIDIEN LP | 596-LEXINGTON | $3,000 | FY2016 |
| VA24915P1881 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 596-LEXINGTON | $38,058 | FY2015 |
| VA24914C0205 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 596-LEXINGTON | $5,133 | FY2014 |
| VA24914C0192 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 596-LEXINGTON | $21,793 | FY2014 |
| VA596C10227 | CERTIFIED INFRARED INC | 596-LEXINGTON | $4,250 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24915P24378_3600_-NONE-_-NONE- · retrieved 2026-09-26.